moomoo ID:0
Log Out
Log in to access Online Inquiry

Top upgrades and downgrades on 3/15

avatarAnalysts Notebookwrote a column03/15 19:27
$Ascendis Pharma A/S(ASND.US)$: BofA Securities Upgrades to Buy from Neutral - PT $161 (from $148)
$GoodRx(GDRX.US)$: Baird Upgrades to Outperform from Neutral - PT $17
$W.W. Grainger(GWW.US)$: Atlantic Equities Upgrades to Overweight from Neutral - PT $580 (from $520)
$Heartland Express(HTLD.US)$: Morgan Stanley Upgrades to Equalweight from Underweight - PT $16
$The Mosaic(MOS.US)$: Goldman Sachs Upgrades to Buy from Neutral - PT $83
$Northern Oil & Gas(NOG.US)$: Johnson Rice Upgrades to Buy from Accumulate - PT $50 (from $370)
$Realty Income(O.US)$: Wolfe Research Upgrades to Outperform from Peerperform - PT $84
$LiveRamp(RAMP.US)$: BMO Capital Upgrades to Outperform from Market Perform - PT $48
$UDR Inc(UDR.US)$: Wolfe Research Upgrades to Outperform from Peerperform - PT $71 (from $60)
$Washington Federal(WAFD.US)$: DA Davidson Upgrades to Buy from Neutral - PT $43 (from $41)
$Zoom Video Communications(ZM.US)$: Benchmark Upgrades To Buy From Hold
$China Eastern Airlines(CEA.US)$: Credit Suisse Downgrades to Underperform from Neutral
$Coupa Software(COUP.US)$: Oppenheimer Downgrades to Perform from Outperform
$Coupa Software(COUP.US)$: Piper Sandler Downgrades to Neutral from Overweight - PT $70 (from $230)
$Evolv Technologies(EVLV.US)$: Stifel Downgrades to Hold from Buy - PT $2 (from $10)
$Hormel Foods(HRL.US)$: Goldman Sachs Downgrades to Sell from Neutral - PT $44
$Nektar Therapeutics(NKTR.US)$: BTIG Downgrades to Neutral From Buy
$Nektar Therapeutics(NKTR.US)$: Cowen Downgrades to Market Perform from Outperform
$Nektar Therapeutics(NKTR.US)$: Mizuho Downgrades to Neutral From Buy - PT $$8 (from $35)
$Prelude Therapeutics(PRLD.US)$: BofA Securities Downgrades to Neutral from Buy - PT $10 (from $50)
$China Southern Airlines(ZNH.US)$: Credit Suisse Downgrades to Neutral from Outperform
$Zynga(ZNGA.US)$: UBS Downgrades to Neutral from Buy - PT $10 (from $13.50)

Moomoo is an app offered by Moomoo Technologies Inc. that provides information about investments. Moomoo Technologies is not an investment adviser or a broker-dealer and it provides neither investment or financial advice nor securities trading services. All contents such as comments and links posted or shared by users of the community are opinions of the respective authors only and do not reflect the opinions, views, or positions of Moomoo Technologies, its affiliates, or any employees of Moomoo Technologies or its affiliates. You are advised to consult a qualified financial or tax advisor for your personal financial planning and tax situations. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.
Analysts Notebook
Sign in to post a comment